Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 70 checked references that resolve
resolves10.1038/nri1886Competence and competition: the challenge of becoming a long-lived plasma cell
resolves10.1084/jem.183.1.227Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts.
resolves10.1007/0-387-24180-9_16Role of the CD19 and CD21/35 Receptor Complex in Innate Immunity, Host Defense and Autoimmunity
resolves10.1093/emboj/17.8.2319Identification of BSAP (Pax‐5) target genes in early B‐cell development by loss‐ and gain‐of‐function experiments
resolves10.1128/MCB.12.6.2662The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP.
resolves10.1038/ni1454Pax5: the guardian of B cell identity and function
resolves10.1189/jlb.0603279CD38 low IgG-secreting cells are precursors of various CD38 high-expressing plasma cell populations
resolves10.1182/blood.V99.6.2154The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
resolves10.1002/cyto.b.20601Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors
resolves10.4049/jimmunol.1000911Secondary Immunization Generates Clonally Related Antigen-Specific Plasma Cells and Memory B Cells
resolves10.1182/blood-2010-01-266536Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab
resolves10.1007/BF01468720Number and distribution of lymphocytes in man. A critical analysis
resolves10.4049/jimmunol.109.6.1386Immunoglobulin Synthesis by Human Lymphoid Tissues: Normal Bone Marrow as a Major Site of IgG Production
resolves10.1182/blood-2004-07-2507Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
resolves10.1002/eji.1830270319Regulatory role of CD95 ligation on human B cells induced <i>in vivo</i> capable of spontaneous and highrate Ig secretion
resolves10.1073/pnas.88.19.8661Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.
resolves10.1186/ar2789Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
resolves10.4049/jimmunol.169.3.1277Chemotactic Responsiveness Toward Ligands for CXCR3 and CXCR4 Is Regulated on Plasma Blasts During the Time Course of a Memory Immune Response
resolves10.1038/nm917Duration of antiviral immunity after smallpox vaccination
resolves10.1084/jem.20040973Plasma Cell Ontogeny Defined by Quantitative Changes in Blimp-1 Expression
resolves10.1016/j.immuni.2006.01.012Gene Repression by Pax5 in B Cells Is Essential for Blood Cell Homeostasis and Is Reversed in Plasma Cells
resolves10.1084/jem.20110040Sustained antibody responses depend on CD28 function in bone marrow–resident plasma cells
resolves10.4049/jimmunol.1100016CD28 Expressed on Malignant Plasma Cells Induces a Prosurvival and Immunosuppressive Microenvironment
resolves10.1002/eji.201344313Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells
resolves10.1038/ni.1981Eosinophils are required for the maintenance of plasma cells in the bone marrow
resolves10.1016/S0002-9440(10)62556-4Expression of CD56/Neural Cell Adhesion Molecule Correlates with the Presence of Lytic Bone Lesions in Multiple Myeloma and Distinguishes Myeloma from Monoclonal Gammopathy of Undetermined Significance and Lymphomas with Plasmacytoid Differentiation
resolves10.1182/blood.V86.8.3151.3151Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin
resolves10.3324/haematol.13740Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
resolves10.1089/scd.2008.0212Comparative Characteristics of Mesenchymal Stem Cells from Human Bone Marrow and Placenta: CD10, CD49d, and CD56 Make a Difference
resolves10.1080/10428190500272549Prognostic relevance of CD56 expression in multiple myeloma: A study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant
resolves10.1182/blood-2008-07-166892Mesenchymal stromal cell–derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction
resolves10.1002/art.22967Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment
resolves10.1002/art.11181Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
resolves10.1016/j.clim.2006.08.016Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE
resolves10.1084/jem.20071555Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+IgD+CD27+ B cell repertoire in infants
resolves10.1084/jem.180.4.1383Variable region gene analysis of B cell subsets derived from a 4-year-old child: somatically mutated memory B cells accumulate in the peripheral blood already at young age.
resolves10.1084/jem.20101352Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
resolves10.1073/pnas.1113395108Differential regulation of self-reactivity discriminates between IgG
<sup>+</sup>
human circulating memory B cells and bone marrow plasma cells
resolves10.1084/jem.20061254High affinity germinal center B cells are actively selected into the plasma cell compartment
resolves10.1182/blood-2005-06-2269Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin
resolves10.1038/nm1763The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
resolves10.1186/ar3909Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
resolves10.1182/blood.V76.2.377.377Plasma cells in multiple myeloma express a natural killer cell- associated antigen: CD56 (NKH-1; Leu-19)
resolves10.1309/AJCP59UORCYZEVQODiagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.